e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Different expression of heme oxygenase-1 in alveolar macrophages in idiopathic interstitial pneumonia
A. Cui, Q. Ye, J. Guzman, U. Costabel (Essen, Bochum, Germany)
Source:
Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session:
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session type:
Thematic Poster Session
Number:
788
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Cui, Q. Ye, J. Guzman, U. Costabel (Essen, Bochum, Germany). Different expression of heme oxygenase-1 in alveolar macrophages in idiopathic interstitial pneumonia. Eur Respir J 2007; 30: Suppl. 51, 788
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 31: 1030-1036
Year: 2008
Haem oxygenase-1 expression is diminished in alveolar macrophages of patients with COPD
Source: Eur Respir J 2004; 23: 652-653
Year: 2004
Impaired haem oxygenase-1 expression in sputum macrophages of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006
Increased heme oxygenase-1 and -2 expression in severe COPD exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 549s
Year: 2003
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002
Serum haem oxygenase-1 as marker of lung function in patients with chronic silicosis
Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease
Year: 2009
Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Increased haemosiderin-laden alveolar macrophages in IPF patients
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
BALF phospholipids and cytokines released by alveolar macrophages in the differential diagnosis of pulmonary sarcoidosis and tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 210s
Year: 2002
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Lysosomal iron in pulmonary alveolar proteinosis: a case report
Source: Eur Respir J 2009; 33: 673-679
Year: 2009
Kaempferol-induced HO-1 expression attenuated inflammation in human pulmonary alveolar epithelial cells
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
Phenotipic diferences between alveolar and interstitial macrophages in acute lung injury induced by pancreatitis
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis
Source: ERJ Open Res, 4 (1) 00071-2017; 10.1183/23120541.00071-2017
Year: 2018
N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease
in vitro
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias
Source: Eur Respir J 2003; 21: 232-240
Year: 2003
The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept